Stabilized Formulations Containing Anti-Interleukin-6 Receptor (Il-6R) Antibodies - EP4098247
The patent EP4098247 was granted to Regeneron Pharmaceuticals on Aug 20, 2025. The application was originally filed on Jan 7, 2011. The patent is currently recorded with a legal status of "Granted".
EP4098247
- Filing Date
- Jan 7, 2011
- Status
- Granted
- Grant Date
- Aug 20, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents